| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Meningioma | 38 | 2024 | 1221 | 6.790 |
Why?
|
| Meningeal Neoplasms | 39 | 2024 | 1249 | 6.520 |
Why?
|
| Brain Neoplasms | 55 | 2024 | 8986 | 3.220 |
Why?
|
| Pituitary Neoplasms | 15 | 2021 | 1313 | 2.150 |
Why?
|
| Skull Base Neoplasms | 6 | 2023 | 269 | 2.000 |
Why?
|
| Radiosurgery | 6 | 2023 | 1343 | 1.520 |
Why?
|
| Glioblastoma | 15 | 2024 | 3484 | 1.380 |
Why?
|
| Craniopharyngioma | 4 | 2021 | 277 | 1.370 |
Why?
|
| Glioma | 21 | 2024 | 3420 | 1.320 |
Why?
|
| Neurosurgical Procedures | 20 | 2024 | 2056 | 1.160 |
Why?
|
| Adenoma | 10 | 2021 | 2148 | 0.960 |
Why?
|
| Neuroma, Acoustic | 5 | 2022 | 459 | 0.940 |
Why?
|
| Neurosurgery | 4 | 2023 | 670 | 0.920 |
Why?
|
| Central Nervous System Neoplasms | 4 | 2024 | 916 | 0.880 |
Why?
|
| Gliosarcoma | 1 | 2021 | 113 | 0.750 |
Why?
|
| Optic Nerve | 1 | 2024 | 567 | 0.710 |
Why?
|
| Craniotomy | 6 | 2020 | 741 | 0.710 |
Why?
|
| Cranial Nerve Neoplasms | 4 | 2022 | 134 | 0.690 |
Why?
|
| Magnetic Resonance Imaging | 33 | 2024 | 36290 | 0.640 |
Why?
|
| Pituitary Apoplexy | 2 | 2016 | 29 | 0.610 |
Why?
|
| Clothing | 1 | 2018 | 97 | 0.590 |
Why?
|
| DNA Copy Number Variations | 7 | 2017 | 2013 | 0.580 |
Why?
|
| Psychophysics | 1 | 2018 | 289 | 0.580 |
Why?
|
| Neoplasm Recurrence, Local | 19 | 2024 | 9276 | 0.580 |
Why?
|
| Patient Transfer | 1 | 2023 | 779 | 0.530 |
Why?
|
| Elasticity | 1 | 2018 | 652 | 0.530 |
Why?
|
| Acromegaly | 2 | 2021 | 306 | 0.520 |
Why?
|
| Mutation | 30 | 2024 | 29932 | 0.520 |
Why?
|
| Humans | 159 | 2024 | 760621 | 0.510 |
Why?
|
| Labyrinth Diseases | 1 | 2017 | 151 | 0.510 |
Why?
|
| Semicircular Canals | 1 | 2017 | 203 | 0.500 |
Why?
|
| Neurilemmoma | 4 | 2022 | 523 | 0.490 |
Why?
|
| Cerebellar Neoplasms | 3 | 2015 | 587 | 0.480 |
Why?
|
| Motion Perception | 1 | 2018 | 372 | 0.470 |
Why?
|
| Chromosomes, Human | 1 | 2016 | 442 | 0.470 |
Why?
|
| Cerebral Veins | 1 | 2015 | 157 | 0.450 |
Why?
|
| Tomography, Spiral Computed | 1 | 2015 | 273 | 0.440 |
Why?
|
| Cerebral Angiography | 2 | 2018 | 1274 | 0.430 |
Why?
|
| Histones | 1 | 2023 | 2583 | 0.420 |
Why?
|
| Cerebral Arteries | 1 | 2015 | 493 | 0.410 |
Why?
|
| Artificial Intelligence | 3 | 2024 | 2557 | 0.410 |
Why?
|
| Prognosis | 22 | 2024 | 29658 | 0.390 |
Why?
|
| Cranial Irradiation | 3 | 2023 | 391 | 0.390 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2021 | 8515 | 0.390 |
Why?
|
| Nervous System Diseases | 2 | 2021 | 1647 | 0.390 |
Why?
|
| Methionine | 1 | 2014 | 569 | 0.380 |
Why?
|
| Length of Stay | 2 | 2024 | 6479 | 0.380 |
Why?
|
| Monitoring, Intraoperative | 2 | 2016 | 942 | 0.370 |
Why?
|
| Facial Nerve | 4 | 2023 | 277 | 0.370 |
Why?
|
| Hospitals | 2 | 2024 | 3928 | 0.370 |
Why?
|
| Hospital Mortality | 1 | 2024 | 5425 | 0.350 |
Why?
|
| Necrosis | 3 | 2023 | 1612 | 0.350 |
Why?
|
| Preoperative Care | 3 | 2019 | 2256 | 0.340 |
Why?
|
| Retrospective Studies | 37 | 2024 | 80372 | 0.340 |
Why?
|
| Tumor Burden | 6 | 2020 | 1895 | 0.320 |
Why?
|
| Skull Base | 4 | 2022 | 291 | 0.320 |
Why?
|
| Insurance Coverage | 1 | 2020 | 1939 | 0.320 |
Why?
|
| Diagnostic Imaging | 2 | 2023 | 3527 | 0.320 |
Why?
|
| Patient Readmission | 2 | 2020 | 3323 | 0.320 |
Why?
|
| Isocitrate Dehydrogenase | 7 | 2023 | 929 | 0.320 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2013 | 1008 | 0.310 |
Why?
|
| Genomics | 9 | 2024 | 5794 | 0.310 |
Why?
|
| Insurance, Health | 1 | 2020 | 2501 | 0.300 |
Why?
|
| Teratoma | 2 | 2015 | 403 | 0.300 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2023 | 5251 | 0.290 |
Why?
|
| Combined Modality Therapy | 11 | 2023 | 8552 | 0.280 |
Why?
|
| Hematoma, Subdural, Chronic | 2 | 2020 | 92 | 0.280 |
Why?
|
| Ubiquitin Thiolesterase | 3 | 2024 | 454 | 0.280 |
Why?
|
| Neuronavigation | 4 | 2024 | 164 | 0.270 |
Why?
|
| Paraneoplastic Polyneuropathy | 1 | 2006 | 2 | 0.270 |
Why?
|
| MELAS Syndrome | 1 | 2006 | 56 | 0.270 |
Why?
|
| Male | 66 | 2024 | 359744 | 0.270 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 13630 | 0.260 |
Why?
|
| Mixed Tumor, Mullerian | 1 | 2006 | 55 | 0.260 |
Why?
|
| Adenoma, Oxyphilic | 2 | 2018 | 148 | 0.260 |
Why?
|
| Astrocytoma | 3 | 2023 | 775 | 0.260 |
Why?
|
| Immunotherapy | 5 | 2023 | 4642 | 0.240 |
Why?
|
| Adult | 48 | 2024 | 219994 | 0.240 |
Why?
|
| Female | 60 | 2024 | 391270 | 0.230 |
Why?
|
| Hematologic Neoplasms | 1 | 2016 | 1895 | 0.230 |
Why?
|
| Neuroendoscopy | 2 | 2016 | 98 | 0.230 |
Why?
|
| Radiopharmaceuticals | 1 | 2014 | 2634 | 0.230 |
Why?
|
| DNA Mutational Analysis | 9 | 2017 | 4107 | 0.230 |
Why?
|
| Rhabdoid Tumor | 2 | 2017 | 210 | 0.230 |
Why?
|
| Sella Turcica | 2 | 2015 | 118 | 0.230 |
Why?
|
| Brain Abscess | 2 | 2015 | 120 | 0.230 |
Why?
|
| Middle Aged | 51 | 2024 | 220352 | 0.230 |
Why?
|
| Telomerase | 2 | 2021 | 746 | 0.220 |
Why?
|
| Epigenesis, Genetic | 2 | 2016 | 3758 | 0.220 |
Why?
|
| Internship and Residency | 1 | 2023 | 5870 | 0.220 |
Why?
|
| Hospitalization | 1 | 2023 | 10790 | 0.220 |
Why?
|
| Ganglia, Spinal | 1 | 2006 | 523 | 0.220 |
Why?
|
| Proto-Oncogene Proteins B-raf | 3 | 2021 | 2053 | 0.210 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2013 | 2385 | 0.210 |
Why?
|
| Pharmacology | 1 | 2003 | 99 | 0.210 |
Why?
|
| Dura Mater | 2 | 2024 | 290 | 0.210 |
Why?
|
| Tissue Adhesives | 1 | 2024 | 173 | 0.200 |
Why?
|
| Brain | 11 | 2024 | 26951 | 0.200 |
Why?
|
| Frozen Sections | 1 | 2002 | 153 | 0.200 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2002 | 426 | 0.200 |
Why?
|
| Pituitary Gland | 2 | 2015 | 637 | 0.190 |
Why?
|
| Neoplasm Seeding | 2 | 2019 | 84 | 0.190 |
Why?
|
| PTEN Phosphohydrolase | 4 | 2021 | 1115 | 0.190 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 13262 | 0.180 |
Why?
|
| Gene Dosage | 4 | 2017 | 1218 | 0.180 |
Why?
|
| Comparative Genomic Hybridization | 6 | 2017 | 473 | 0.180 |
Why?
|
| Aged | 32 | 2024 | 169152 | 0.170 |
Why?
|
| Neurofibromin 1 | 1 | 2021 | 190 | 0.170 |
Why?
|
| Cerebellopontine Angle | 2 | 2021 | 53 | 0.170 |
Why?
|
| GATA2 Transcription Factor | 1 | 2020 | 158 | 0.170 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 908 | 0.170 |
Why?
|
| Pneumocephalus | 1 | 2020 | 47 | 0.170 |
Why?
|
| Biology | 1 | 2022 | 290 | 0.170 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2005 | 494 | 0.170 |
Why?
|
| Laminectomy | 2 | 2018 | 224 | 0.170 |
Why?
|
| Oncolytic Viruses | 1 | 2023 | 343 | 0.170 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2020 | 67 | 0.170 |
Why?
|
| Facial Paralysis | 1 | 2023 | 345 | 0.170 |
Why?
|
| Co-Repressor Proteins | 1 | 2020 | 191 | 0.170 |
Why?
|
| Cranial Sinuses | 1 | 2019 | 68 | 0.160 |
Why?
|
| Multilingualism | 1 | 2020 | 87 | 0.160 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 2019 | 31 | 0.160 |
Why?
|
| Chromosome Aberrations | 2 | 2016 | 1764 | 0.160 |
Why?
|
| Salvage Therapy | 3 | 2019 | 1268 | 0.160 |
Why?
|
| Molecular Targeted Therapy | 3 | 2019 | 2803 | 0.160 |
Why?
|
| Postoperative Complications | 10 | 2023 | 15697 | 0.160 |
Why?
|
| Hydrogels | 1 | 2024 | 723 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 698 | 0.150 |
Why?
|
| Pituitary ACTH Hypersecretion | 1 | 2021 | 178 | 0.150 |
Why?
|
| Collateral Circulation | 1 | 2019 | 292 | 0.150 |
Why?
|
| Phlebography | 2 | 2019 | 325 | 0.150 |
Why?
|
| Tumor Microenvironment | 5 | 2023 | 3844 | 0.150 |
Why?
|
| Herpesvirus 1, Human | 1 | 2023 | 753 | 0.150 |
Why?
|
| Treatment Outcome | 17 | 2024 | 65017 | 0.150 |
Why?
|
| Interneurons | 1 | 2002 | 591 | 0.150 |
Why?
|
| Oncolytic Virotherapy | 1 | 2023 | 515 | 0.150 |
Why?
|
| Decompression, Surgical | 3 | 2018 | 604 | 0.150 |
Why?
|
| Genome, Human | 4 | 2020 | 4417 | 0.150 |
Why?
|
| Syringomyelia | 1 | 2018 | 67 | 0.150 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2002 | 893 | 0.140 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2018 | 2802 | 0.140 |
Why?
|
| Endoscopy | 3 | 2016 | 1838 | 0.140 |
Why?
|
| Databases, Factual | 2 | 2024 | 8035 | 0.140 |
Why?
|
| DNA Methylation | 4 | 2024 | 4373 | 0.140 |
Why?
|
| Cell Separation | 1 | 2002 | 1720 | 0.140 |
Why?
|
| Prospective Studies | 6 | 2023 | 54303 | 0.140 |
Why?
|
| Nerve Tissue Proteins | 3 | 2007 | 4407 | 0.140 |
Why?
|
| Gonadotrophs | 1 | 2016 | 19 | 0.140 |
Why?
|
| Cohort Studies | 9 | 2024 | 41335 | 0.140 |
Why?
|
| Cell Lineage | 2 | 2017 | 2533 | 0.140 |
Why?
|
| Uterine Neoplasms | 1 | 2006 | 1439 | 0.140 |
Why?
|
| Neoplasms, Second Primary | 1 | 2005 | 1056 | 0.140 |
Why?
|
| Brevican | 2 | 2014 | 5 | 0.140 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2018 | 150 | 0.140 |
Why?
|
| Neurofibromatoses | 1 | 2020 | 299 | 0.140 |
Why?
|
| Chromogranins | 1 | 2017 | 161 | 0.140 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2021 | 2919 | 0.140 |
Why?
|
| Hematoma, Subdural, Acute | 1 | 2016 | 16 | 0.130 |
Why?
|
| Neoplasms, Neuroepithelial | 1 | 2016 | 42 | 0.130 |
Why?
|
| Sphenoid Sinus | 1 | 2016 | 99 | 0.130 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2018 | 158 | 0.130 |
Why?
|
| Ear Neoplasms | 1 | 2016 | 118 | 0.130 |
Why?
|
| World Health Organization | 1 | 2022 | 1312 | 0.130 |
Why?
|
| Medical Oncology | 2 | 2024 | 2313 | 0.130 |
Why?
|
| American Civil War | 1 | 2015 | 8 | 0.130 |
Why?
|
| Neural Tube Defects | 1 | 2018 | 254 | 0.130 |
Why?
|
| Ganglioglioma | 1 | 2015 | 36 | 0.130 |
Why?
|
| Hyponatremia | 1 | 2018 | 279 | 0.130 |
Why?
|
| INDEL Mutation | 1 | 2016 | 266 | 0.130 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 195 | 0.130 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2018 | 727 | 0.130 |
Why?
|
| Endocrine Surgical Procedures | 1 | 2015 | 32 | 0.130 |
Why?
|
| Young Adult | 18 | 2024 | 58741 | 0.130 |
Why?
|
| Psychosurgery | 1 | 2015 | 86 | 0.130 |
Why?
|
| Pinealoma | 1 | 2015 | 51 | 0.130 |
Why?
|
| Molecular Chaperones | 1 | 2020 | 752 | 0.120 |
Why?
|
| Chordoma | 1 | 2018 | 346 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2022 | 3616 | 0.120 |
Why?
|
| Odontoid Process | 1 | 2015 | 46 | 0.120 |
Why?
|
| DNA, Neoplasm | 2 | 2017 | 1745 | 0.120 |
Why?
|
| Rhizopus | 1 | 2014 | 22 | 0.120 |
Why?
|
| Infratentorial Neoplasms | 1 | 2015 | 98 | 0.120 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 1913 | 0.120 |
Why?
|
| Pituitary Diseases | 1 | 2015 | 135 | 0.120 |
Why?
|
| Vestibule, Labyrinth | 1 | 2016 | 232 | 0.120 |
Why?
|
| Famous Persons | 1 | 2015 | 109 | 0.120 |
Why?
|
| Medicine | 1 | 2003 | 943 | 0.120 |
Why?
|
| Baseball | 1 | 2015 | 95 | 0.120 |
Why?
|
| Skull Neoplasms | 1 | 2015 | 173 | 0.120 |
Why?
|
| Transcription Factors | 5 | 2024 | 12103 | 0.120 |
Why?
|
| Head Protective Devices | 1 | 2015 | 118 | 0.120 |
Why?
|
| Endopeptidases | 1 | 2018 | 772 | 0.110 |
Why?
|
| Liability, Legal | 1 | 2015 | 210 | 0.110 |
Why?
|
| Melanoma | 3 | 2022 | 5697 | 0.110 |
Why?
|
| Epidural Space | 1 | 2015 | 122 | 0.110 |
Why?
|
| Basal Ganglia Diseases | 1 | 2014 | 144 | 0.110 |
Why?
|
| Meningitis, Bacterial | 1 | 2016 | 221 | 0.110 |
Why?
|
| Gene Expression Profiling | 5 | 2023 | 9411 | 0.110 |
Why?
|
| Telomere | 1 | 2020 | 933 | 0.110 |
Why?
|
| Semantics | 1 | 2017 | 599 | 0.110 |
Why?
|
| History, 20th Century | 5 | 2022 | 2773 | 0.110 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2015 | 334 | 0.110 |
Why?
|
| Diskectomy | 1 | 2015 | 209 | 0.110 |
Why?
|
| Epidural Abscess | 1 | 2015 | 94 | 0.110 |
Why?
|
| Medulla Oblongata | 1 | 2015 | 248 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2019 | 8950 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2014 | 385 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 6068 | 0.110 |
Why?
|
| Mucormycosis | 1 | 2014 | 103 | 0.110 |
Why?
|
| Functional Laterality | 1 | 2020 | 2253 | 0.110 |
Why?
|
| Military Personnel | 1 | 2022 | 1244 | 0.110 |
Why?
|
| Video Recording | 1 | 2018 | 955 | 0.110 |
Why?
|
| Oligodendroglioma | 1 | 2014 | 279 | 0.110 |
Why?
|
| Hydrocortisone | 1 | 2021 | 1803 | 0.100 |
Why?
|
| Neoplasms | 2 | 2019 | 22072 | 0.100 |
Why?
|
| Morbidity | 1 | 2018 | 1765 | 0.100 |
Why?
|
| Ependymoma | 1 | 2016 | 320 | 0.100 |
Why?
|
| beta Catenin | 1 | 2018 | 1043 | 0.100 |
Why?
|
| Radiation Injuries | 1 | 2020 | 1183 | 0.100 |
Why?
|
| Venous Thrombosis | 1 | 2022 | 1299 | 0.100 |
Why?
|
| Microsurgery | 2 | 2015 | 796 | 0.100 |
Why?
|
| Follow-Up Studies | 8 | 2021 | 39261 | 0.100 |
Why?
|
| Aged, 80 and over | 13 | 2020 | 58995 | 0.100 |
Why?
|
| Scalp | 1 | 2015 | 389 | 0.100 |
Why?
|
| Nuclear Proteins | 4 | 2024 | 5791 | 0.100 |
Why?
|
| Social Class | 1 | 2021 | 2005 | 0.100 |
Why?
|
| Disease Progression | 8 | 2019 | 13502 | 0.100 |
Why?
|
| Brachytherapy | 1 | 2019 | 1238 | 0.100 |
Why?
|
| RNA, Messenger | 3 | 2017 | 12766 | 0.100 |
Why?
|
| Regional Blood Flow | 1 | 2015 | 1490 | 0.100 |
Why?
|
| Oncogenes | 1 | 2017 | 1220 | 0.100 |
Why?
|
| Massachusetts | 1 | 2024 | 8803 | 0.100 |
Why?
|
| Postoperative Period | 3 | 2021 | 1818 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2022 | 3484 | 0.090 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2016 | 643 | 0.090 |
Why?
|
| Malpractice | 1 | 2015 | 556 | 0.090 |
Why?
|
| Cell Line, Tumor | 7 | 2022 | 16939 | 0.090 |
Why?
|
| Language | 1 | 2020 | 1533 | 0.090 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 1652 | 0.090 |
Why?
|
| Curriculum | 1 | 2023 | 3718 | 0.090 |
Why?
|
| Patient Discharge | 1 | 2023 | 3476 | 0.090 |
Why?
|
| Societies, Medical | 1 | 2022 | 3905 | 0.090 |
Why?
|
| Radionuclide Imaging | 1 | 2014 | 1975 | 0.090 |
Why?
|
| Spinal Neoplasms | 1 | 2016 | 716 | 0.090 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2016 | 615 | 0.090 |
Why?
|
| Neurofibromin 2 | 2 | 2023 | 270 | 0.080 |
Why?
|
| SEER Program | 3 | 2022 | 1530 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 1484 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2019 | 3340 | 0.080 |
Why?
|
| Mutation, Missense | 1 | 2018 | 2566 | 0.080 |
Why?
|
| Venous Thromboembolism | 1 | 2022 | 1864 | 0.080 |
Why?
|
| Animals | 14 | 2024 | 167963 | 0.080 |
Why?
|
| Brain Diseases | 1 | 2018 | 1540 | 0.080 |
Why?
|
| Algorithms | 3 | 2019 | 13981 | 0.080 |
Why?
|
| Evolution, Molecular | 1 | 2017 | 1885 | 0.080 |
Why?
|
| Pulmonary Embolism | 1 | 2022 | 2543 | 0.080 |
Why?
|
| Epilepsy | 1 | 2024 | 3267 | 0.080 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1728 | 0.080 |
Why?
|
| Ultrasonography | 2 | 2024 | 5961 | 0.080 |
Why?
|
| Adolescent | 14 | 2023 | 87810 | 0.080 |
Why?
|
| Survival Rate | 6 | 2019 | 12808 | 0.080 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2016 | 951 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2023 | 4783 | 0.070 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 5761 | 0.070 |
Why?
|
| Spine | 1 | 2015 | 1111 | 0.070 |
Why?
|
| Child, Preschool | 5 | 2023 | 42063 | 0.070 |
Why?
|
| Medicaid | 1 | 2020 | 2815 | 0.070 |
Why?
|
| Clinical Trials as Topic | 2 | 2022 | 8056 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2024 | 20509 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 4 | 2020 | 4713 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 4902 | 0.070 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 1347 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 2864 | 0.070 |
Why?
|
| Health Care Reform | 1 | 2015 | 1245 | 0.070 |
Why?
|
| Genome-Wide Association Study | 2 | 2016 | 12626 | 0.070 |
Why?
|
| Reproducibility of Results | 5 | 2024 | 20080 | 0.070 |
Why?
|
| Recovery of Function | 1 | 2016 | 2985 | 0.070 |
Why?
|
| United States | 8 | 2022 | 72461 | 0.070 |
Why?
|
| Neoadjuvant Therapy | 1 | 2017 | 2821 | 0.070 |
Why?
|
| Macrophages | 1 | 2020 | 5745 | 0.060 |
Why?
|
| DNA-Binding Proteins | 3 | 2018 | 9585 | 0.060 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2007 | 247 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 2828 | 0.060 |
Why?
|
| Arachnoid Cysts | 1 | 2006 | 61 | 0.060 |
Why?
|
| Preoperative Period | 2 | 2018 | 555 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 25942 | 0.060 |
Why?
|
| Hemianopsia | 1 | 2006 | 121 | 0.060 |
Why?
|
| Remission Induction | 2 | 2021 | 2392 | 0.060 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2006 | 186 | 0.060 |
Why?
|
| DNA Helicases | 2 | 2024 | 854 | 0.060 |
Why?
|
| Brain Mapping | 1 | 2020 | 6568 | 0.060 |
Why?
|
| Ascites | 1 | 2006 | 338 | 0.060 |
Why?
|
| Brain Concussion | 1 | 2015 | 1394 | 0.060 |
Why?
|
| Consensus | 2 | 2024 | 3113 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 11712 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 5649 | 0.060 |
Why?
|
| Gene Expression | 1 | 2016 | 7588 | 0.060 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2019 | 1791 | 0.060 |
Why?
|
| Basal Ganglia | 1 | 2006 | 552 | 0.060 |
Why?
|
| Survivors | 1 | 2014 | 2375 | 0.060 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 7818 | 0.060 |
Why?
|
| Equipment Failure | 1 | 2006 | 577 | 0.060 |
Why?
|
| Brain Injuries | 1 | 2015 | 2044 | 0.050 |
Why?
|
| Korean War | 1 | 2022 | 6 | 0.050 |
Why?
|
| History, 19th Century | 2 | 2015 | 720 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2017 | 3976 | 0.050 |
Why?
|
| Carbocyanines | 1 | 2002 | 175 | 0.050 |
Why?
|
| Wounds and Injuries | 1 | 2015 | 2477 | 0.050 |
Why?
|
| Rhodamines | 1 | 2002 | 179 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2002 | 174 | 0.050 |
Why?
|
| Postoperative Care | 2 | 2019 | 1479 | 0.050 |
Why?
|
| Vestibulocochlear Nerve | 1 | 2021 | 115 | 0.050 |
Why?
|
| Atrophy | 1 | 2006 | 1627 | 0.050 |
Why?
|
| Predictive Value of Tests | 4 | 2021 | 15289 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2023 | 508 | 0.050 |
Why?
|
| Genetic Testing | 1 | 2014 | 3531 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7475 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 9185 | 0.050 |
Why?
|
| Computer Systems | 1 | 2002 | 470 | 0.050 |
Why?
|
| Hydrazines | 1 | 2002 | 224 | 0.050 |
Why?
|
| Seizures | 2 | 2024 | 2917 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 3584 | 0.050 |
Why?
|
| Calibration | 1 | 2023 | 816 | 0.050 |
Why?
|
| Neoplasm, Residual | 2 | 2016 | 1007 | 0.040 |
Why?
|
| Subdural Space | 1 | 2020 | 38 | 0.040 |
Why?
|
| ACTH-Secreting Pituitary Adenoma | 1 | 2021 | 63 | 0.040 |
Why?
|
| Child | 8 | 2023 | 79806 | 0.040 |
Why?
|
| Incidence | 4 | 2022 | 21392 | 0.040 |
Why?
|
| Huntington Disease | 1 | 2007 | 1141 | 0.040 |
Why?
|
| Sagittal Sinus Thrombosis | 1 | 2019 | 11 | 0.040 |
Why?
|
| Lateral Sinus Thrombosis | 1 | 2019 | 7 | 0.040 |
Why?
|
| Ultrasonography, Doppler | 1 | 2022 | 465 | 0.040 |
Why?
|
| Reoperation | 3 | 2018 | 4291 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 14660 | 0.040 |
Why?
|
| Immunohistochemistry | 3 | 2021 | 11071 | 0.040 |
Why?
|
| Reference Standards | 1 | 2023 | 1004 | 0.040 |
Why?
|
| Interleukin-12 | 1 | 2022 | 584 | 0.040 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2015 | 3763 | 0.040 |
Why?
|
| Unemployment | 1 | 2021 | 209 | 0.040 |
Why?
|
| Cognition | 1 | 2017 | 6957 | 0.040 |
Why?
|
| Pathology, Molecular | 1 | 2022 | 329 | 0.040 |
Why?
|
| Genetic Markers | 2 | 2015 | 2608 | 0.040 |
Why?
|
| New England | 1 | 2022 | 1050 | 0.040 |
Why?
|
| Random Allocation | 1 | 2023 | 2394 | 0.040 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2021 | 618 | 0.040 |
Why?
|
| Geography | 1 | 2021 | 661 | 0.040 |
Why?
|
| Lasers | 1 | 2002 | 952 | 0.040 |
Why?
|
| Syndrome | 1 | 2005 | 3280 | 0.040 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2018 | 142 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2002 | 1690 | 0.040 |
Why?
|
| Ecosystem | 1 | 2022 | 485 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 2448 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2002 | 707 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2023 | 10182 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2019 | 347 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2020 | 786 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2022 | 633 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2018 | 23376 | 0.040 |
Why?
|
| Head | 1 | 2023 | 922 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2022 | 4550 | 0.040 |
Why?
|
| Perioperative Period | 1 | 2019 | 264 | 0.040 |
Why?
|
| Face | 1 | 2023 | 1017 | 0.040 |
Why?
|
| Cerebellar Diseases | 1 | 2019 | 219 | 0.040 |
Why?
|
| Mice | 6 | 2022 | 81208 | 0.040 |
Why?
|
| Brain Infarction | 1 | 2019 | 292 | 0.040 |
Why?
|
| Automation | 1 | 2019 | 580 | 0.040 |
Why?
|
| DNA Mismatch Repair | 1 | 2020 | 429 | 0.030 |
Why?
|
| Hypophysectomy | 1 | 2016 | 114 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2024 | 1334 | 0.030 |
Why?
|
| Mammals | 1 | 2022 | 1131 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2019 | 635 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2020 | 2014 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2006 | 3765 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 2002 | 1233 | 0.030 |
Why?
|
| Limit of Detection | 1 | 2017 | 280 | 0.030 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2020 | 618 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2020 | 1234 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2017 | 138 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2022 | 1575 | 0.030 |
Why?
|
| Phenotype | 3 | 2020 | 16546 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 616 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2015 | 6796 | 0.030 |
Why?
|
| Verbal Behavior | 1 | 2017 | 335 | 0.030 |
Why?
|
| Cranial Nerve Injuries | 1 | 2015 | 28 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 5799 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2020 | 1871 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2016 | 516 | 0.030 |
Why?
|
| Medically Uninsured | 1 | 2021 | 843 | 0.030 |
Why?
|
| Head Injuries, Penetrating | 1 | 2015 | 28 | 0.030 |
Why?
|
| Rats | 3 | 2014 | 23711 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2023 | 2326 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2020 | 1229 | 0.030 |
Why?
|
| Cadaver | 1 | 2019 | 1345 | 0.030 |
Why?
|
| Risk Factors | 5 | 2022 | 74359 | 0.030 |
Why?
|
| Sphenoid Bone | 1 | 2016 | 177 | 0.030 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2016 | 306 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2018 | 17790 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2006 | 2782 | 0.030 |
Why?
|
| Health Resources | 1 | 2021 | 935 | 0.030 |
Why?
|
| Trigeminal Nerve Diseases | 1 | 2015 | 49 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1088 | 0.030 |
Why?
|
| Pineal Gland | 1 | 2015 | 157 | 0.030 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2016 | 725 | 0.030 |
Why?
|
| Biopsy | 2 | 2017 | 6771 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2019 | 4048 | 0.030 |
Why?
|
| Cell Survival | 2 | 2014 | 5797 | 0.030 |
Why?
|
| Pons | 1 | 2015 | 239 | 0.030 |
Why?
|
| Swine | 1 | 2024 | 5899 | 0.030 |
Why?
|
| Gene Fusion | 1 | 2016 | 354 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 2016 | 749 | 0.030 |
Why?
|
| Therapeutic Irrigation | 1 | 2015 | 292 | 0.030 |
Why?
|
| Clone Cells | 1 | 2017 | 1660 | 0.030 |
Why?
|
| Educational Status | 1 | 2021 | 2515 | 0.030 |
Why?
|
| Steroids | 1 | 2018 | 928 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2019 | 2648 | 0.030 |
Why?
|
| Brain Stem Neoplasms | 1 | 2015 | 190 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2020 | 3615 | 0.030 |
Why?
|
| Wakefulness | 1 | 2020 | 1255 | 0.030 |
Why?
|
| Observer Variation | 1 | 2019 | 2601 | 0.030 |
Why?
|
| Leadership | 1 | 2022 | 1371 | 0.030 |
Why?
|
| Rats, Inbred Lew | 1 | 2014 | 1154 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2024 | 3446 | 0.030 |
Why?
|
| Surgical Instruments | 1 | 2015 | 385 | 0.030 |
Why?
|
| Homicide | 1 | 2015 | 295 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2018 | 908 | 0.030 |
Why?
|
| Income | 1 | 2021 | 1875 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2015 | 916 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2019 | 1431 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 1837 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2005 | 4938 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2018 | 10446 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2016 | 1636 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2018 | 3607 | 0.020 |
Why?
|
| Age Factors | 2 | 2021 | 18416 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 895 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2002 | 8158 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2016 | 1021 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2016 | 2627 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2020 | 2299 | 0.020 |
Why?
|
| Nose | 1 | 2015 | 519 | 0.020 |
Why?
|
| Hearing | 1 | 2015 | 501 | 0.020 |
Why?
|
| Genotype | 2 | 2016 | 12960 | 0.020 |
Why?
|
| Infant | 3 | 2018 | 36060 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 2018 | 1501 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2015 | 1387 | 0.020 |
Why?
|
| Chromatin | 1 | 2022 | 2938 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2017 | 2913 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 3618 | 0.020 |
Why?
|
| Drainage | 1 | 2015 | 1161 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2013 | 1578 | 0.020 |
Why?
|
| Visual Fields | 1 | 2016 | 1054 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2015 | 12965 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2014 | 1832 | 0.020 |
Why?
|
| Intracranial Hemorrhages | 1 | 2015 | 844 | 0.020 |
Why?
|
| Autophagy | 1 | 2017 | 1337 | 0.020 |
Why?
|
| Wounds, Gunshot | 1 | 2015 | 581 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2021 | 2571 | 0.020 |
Why?
|
| Poverty | 1 | 2021 | 2695 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2022 | 3598 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2015 | 1513 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 1841 | 0.020 |
Why?
|
| Exons | 1 | 2014 | 2388 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 2005 | 0.020 |
Why?
|
| Recurrence | 1 | 2021 | 8482 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2017 | 2058 | 0.020 |
Why?
|
| Time Factors | 2 | 2016 | 40165 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 6544 | 0.020 |
Why?
|
| Cerebellum | 1 | 2015 | 1496 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2015 | 1688 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 2 | 2016 | 7408 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2018 | 8313 | 0.020 |
Why?
|
| Memory | 1 | 2017 | 2179 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 7806 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2015 | 3529 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 1726 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 6131 | 0.020 |
Why?
|
| Attention | 1 | 2017 | 2387 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2022 | 4897 | 0.020 |
Why?
|
| Cell Movement | 1 | 2018 | 5206 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2007 | 622 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 10181 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 6828 | 0.020 |
Why?
|
| Twins, Monozygotic | 1 | 2007 | 469 | 0.020 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2005 | 141 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 3442 | 0.020 |
Why?
|
| Diseases in Twins | 1 | 2007 | 447 | 0.020 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2006 | 195 | 0.020 |
Why?
|
| Ventriculostomy | 1 | 2006 | 131 | 0.010 |
Why?
|
| Computational Biology | 1 | 2016 | 3505 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 5785 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 14495 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2007 | 2262 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2018 | 3836 | 0.010 |
Why?
|
| Genomic Instability | 1 | 2007 | 704 | 0.010 |
Why?
|
| DNA Primers | 1 | 2007 | 2819 | 0.010 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 3202 | 0.010 |
Why?
|
| Boston | 1 | 2015 | 9280 | 0.010 |
Why?
|
| Critical Care | 1 | 2015 | 2699 | 0.010 |
Why?
|
| Glycosylation | 1 | 2005 | 1096 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2015 | 8555 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 5253 | 0.010 |
Why?
|
| Lectins, C-Type | 1 | 2005 | 587 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 22023 | 0.010 |
Why?
|
| Early Diagnosis | 1 | 2006 | 1180 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 12531 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2005 | 1697 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11152 | 0.010 |
Why?
|
| Heart Atria | 1 | 2006 | 1346 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 4024 | 0.010 |
Why?
|
| Visual Cortex | 1 | 2007 | 1089 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 10344 | 0.010 |
Why?
|
| Pediatrics | 1 | 2014 | 3586 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2018 | 26181 | 0.010 |
Why?
|
| Apoptosis | 1 | 2014 | 9501 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 15789 | 0.010 |
Why?
|
| Transfection | 1 | 2005 | 5781 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2014 | 11481 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 12446 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2005 | 3682 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2007 | 9530 | 0.010 |
Why?
|
| Neurons | 1 | 2007 | 9426 | 0.000 |
Why?
|